KPRX earnings date and last-quarter result: next report 2026-08-07, last quarter beat, P/E -0.95. Updated 2026-07-23.
Kiora Pharmaceuticals (KPRX) Research Hub
Kiora Pharmaceuticals (KPRX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 2.21 USD (-3.49%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.95, market cap 0.01B. This hub links to the full technical, earnings and options research available for KPRX.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.21 USD (-3.49%) |
| 52-week range | 2.21 USD – 2.85 USD |
| Trend regime | Range |
| 14-day RSI | 16.3 (Oversold) |
| Trailing P/E | -0.95 |
| Market cap | 0.01B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-07 |
Available research for KPRX
Covered Call on KPRX: how it works, illustrative setup around the real 2.21 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on KPRX: how it works, illustrative setup around the real 2.21 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on KPRX: how it works, illustrative setup around the real 2.21 USD price, max profit/loss, breakeven and when to use it. Educational.
KPRX technical analysis: range, last 2.21 USD, RSI 16.3, 52w range 2.21 USD–2.85 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is KPRX in?
Kiora Pharmaceuticals (KPRX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is KPRX in an uptrend or downtrend?
As of 2026-10-26, KPRX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is KPRX's trailing P/E ratio?
KPRX's trailing P/E is -0.95, with a market cap of 0.01B. See the earnings research page for full valuation detail.
When does KPRX next report earnings?
KPRX is next scheduled to report earnings on 2026-08-07.